Skip to main content
. 2023 Jun 3;16:3525–3533. doi: 10.2147/IDR.S408956

Table 3.

Distribution of Drug Susceptibility for Pseudomonas aeruginosa

Antibacterial Category 2016 (n=505) 2017 (n=479) 2018 (n=476) 2019 (n=539) 2020 (n=504) 2021 (n=614) 2022 (n=184) Total (n=3301)
AMK Resistance 0 (0.00%) 1 (0.21%) 3 (0.63%) 20 (3.71%) 15 (2.98%) 35 (5.70%) 5 (2.72%) 79 (2.39%)
Intermediate 26 (5.15%) 28 (5.85%) 38 (7.98%) 14 (2.60%) 14 (2.78%) 15 (2.44%) 4 (2.17%) 139 (4.21%)
Sensitivity 441 (87.33%) 450 (93.95%) 432 (90.76%) 503 (93.32%) 471 (93.45%) 561 (91.37%) 173 (94.02%) 3031 (91.82%)
ATM Resistance 0 (0.00%) 3 (0.63%) 17 (3.57%) 42 (7.79%) 41 (8.13%) 98 (15.96%) 26 (14.13%) 227 (6.88%)
Intermediate 191 (38.42%) 180 (37.58%) 181 (38.03%) 34 (6.31%) 18 (3.57%) 54 (8.79%) 14 (7.61%) 672 (20.36%)
Sensitivity 270 (53.47%) 285 (59.50%) 258 (54.20%) 250 (46.38%) 215 (42.66%) 383 (62.38%) 137 (74.46%) 1798 (54.47%)
POL Resistance 1 (0.20%) 0 (0.00%) 1 (0.21%) 1 (0.19%) 0 (0.00%) 0 (0.00%) 3 (1.63%) 6 (0.18%)
Intermediate 31 (6.14%) 34 (7.10%) 95 (19.96%) 319 (59.18%) 261 (51.79%) 528 (85.99%) 171 (92.93%) 1439 (43.59%)
Sensitivity 416 (82.38%) 436 (91.02%) 366 (76.89%) 5 (0.93%) 1 (0.20%) 5 (0.81%) 3 (1.63%) 1232 (37.32%)
CIP Resistance 93 (18.42%) 96 (20.04%) 90 (18.91%) 86 (15.96%) 96 (19.05%) 117 (19.06%) 36 (19.57%) 614 (18.60%)
Intermediate 371 (73.47%) 379 (79.12%) 378 (79.41%) 285 (52.88%) 229 (45.44%) 434 (70.68%) 142 (77.17%) 2218 (67.19%)
Sensitivity 0 (0.00%) 1 (0.21%) 3 (0.63%) 164 (30.43%) 175 (34.72%) 59 (9.61%) 3 (1.63%) 405 (12.27%)
MEM Resistance 67 (13.27%) 59 (12.32%) 62 (13.03%) 22 (4.08%) 14 (2.78%) 28 (4.56%) 7 (3.80%) 259 (7.85%)
Intermediate 21 (4.16%) 18 (3.76%) 10 (2.10%) 11 (2.04%) 6 (1.19%) 18 (2.93%) 11 (5.98%) 95 (2.88%)
Sensitivity 369 (73.07%) 398 (81.21%) 403 (84.66%) 291 (53.99%) 252 (50.00%) 489 (79.64%) 159 (86.41%) 2361 (71.52%)
PIP Resistance 62 (12.28%) 98 (20.46%) 100 (21.01%) 55 (10.20%) 39 (7.74%) 96 (15.64%) 24 (13.04%) 474 (14.36%)
Intermediate 38 (7.52%) 44 (9.19%) 44 (9.24%) 25 (4.64%) 25 (4.96%) 61 (9.93%) 12 (6.52%) 249 (7.54%)
Sensitivity 360 (71.29%) 324 (67.64%) 325 (68.28%) 241 (44.71%) 208 (41.27%) 371 (60.42%) 137 (74.46%) 1966 (59.56%)
TZP Resistance 50 (9.90%) 64 (13.36%) 53 (11.13%) 52 (9.65%) 37 (7.34%) 59 (9.61%) 17 (9.24%) 332 (10.06%)
Intermediate 34 (6.73%) 42 (8.77%) 56 (11.76%) 73 (13.54%) 65 (12.90%) 77 (12.54%) 14 (7.61%) 361 (10.94%)
Sensitivity 380 (75.25%) 366 (76.41%) 350 (73.53%) 411 (76.25%) 397 (78.77%) 475 (77.36%) 151 (82.07%) 2530 (76.64%)
GEN Resistance 0 (0.00%) 1 (0.21%) 9 (1.89%) 43 (7.98%) 42 (8.33%) 74 (12.05%) 24 (13.04%) 193 (5.85%)
Intermediate 95 (18.81%) 82 (17.12%) 72 (15.13%) 26 (4.82%) 32 (6.35%) 20 (3.26%) 6 (3.26%) 333 (10.09%)
Sensitivity 370 (73.27%) 394 (82.25%) 393 (82.56%) 466 (86.46%) 420 (83.33%) 513 (83.55%) 151 (82.07%) 2707 (82.01%)
TCC Resistance 173 (34.26%) 128 (26.72%) 161 (33.82%) 74 (13.73%) 62 (12.30%) 118 (19.22%) 29 (15.76%) 745 (22.57%)
Intermediate 234 (46.34%) 179 (37.37%) 178 (37.39%) 121 (22.45%) 106 (21.03%) 188 (30.62%) 64 (34.78%) 1070 (32.41%)
Sensitivity 49 (9.70%) 33 (6.89%) 47 (9.87%) 130 (24.12%) 103 (20.44%) 226 (36.81%) 83 (45.11%) 671 (20.33%)
FEP Resistance 0 (0.00%) 2 (0.42%) 8 (1.68%) 47 (8.72%) 45 (8.93%) 63 (10.26%) 13 (7.07%) 178 (5.39%)
Intermediate 85 (16.83%) 109 (22.76%) 110 (23.11%) 45 (8.35%) 30 (5.95%) 48 (7.82%) 15 (8.15%) 442 (13.39%)
Sensitivity 379 (75.05%) 365 (76.20%) 353 (74.16%) 445 (82.56%) 423 (83.93%) 500 (81.43%) 154 (83.70%) 2619 (79.34%)
CSL Resistance 8 (1.58%) 6 (1.25%) 10 (2.10%) 0 (0.00%) 18 (3.57%) 87 (14.17%) 24 (13.04%) 153 (4.63%)
Intermediate 12 (2.38%) 1 (0.21%) 1 (0.21%) 0 (0.00%) 19 (3.77%) 78 (12.70%) 30 (16.30%) 141 (4.27%)
Sensitivity 31 (6.14%) 23 (4.80%) 28 (5.88%) 0 (0.00%) 121 (24.01%) 317 (51.63%) 123 (66.85%) 643 (19.48%)
CAZ Resistance 0 (0.00%) 1 (0.21%) 11 (2.31%) 72 (13.36%) 62 (12.30%) 93 (15.15%) 18 (9.78%) 257 (7.79%)
Intermediate 91 (18.02%) 102 (21.29%) 101 (21.22%) 33 (6.12%) 36 (7.14%) 37 (6.03%) 4 (2.17%) 404 (12.24%)
Sensitivity 376 (74.46%) 372 (77.66%) 362 (76.05%) 432 (80.15%) 401 (79.56%) 480 (78.18%) 160 (86.96%) 2583 (78.25%)
TOB Resistance 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%)
Intermediate 94 (18.61%) 79 (16.79%) 81 (17.02%) 65 (12.06%) 73 (14.48%) 93 (15.15%) 32 (17.39%) 517 (15.66%)
Sensitivity 373 (73.86%) 400 (83.51%) 395 (82.98%) 471 (87.38%) 427 (84.72%) 517 (84.20%) 150 (81.52%) 2733 (82.79%)
IPM Resistance 38 (7.52%) 43 (8.98%) 55 (11.55%) 88 (16.33%) 107 (21.23%) 136 (22.15%) 28 (15.22%) 495 (15.00%)
Intermediate 51 (10.10%) 36 (7.52%) 26 (5.46%) 29 (5.38%) 13 (2.58%) 14 (2.28%) 8 (4.35%) 177 (5.36%)
Sensitivity 367 (72.67%) 392 (81.84%) 389 (81.72%) 416 (77.18%) 378 (75.00%) 456 (74.27%) 146 (79.35%) 2544 (77.07%)
COL Resistance 1 (0.20%) 0 (0.00%) 2 (0.42%) 1 (0.19%) 0 (0.00%) 0 (0.00%) 2 (1.09%) 6 (0.18%)
Intermediate 11 (2.18%) 19 (3.97%) 95 (19.96%) 317 (58.81%) 260 (51.59%) 523 (85.18%) 171 (92.93%) 1396 (42.29%)
Sensitivity 426 (84.36%) 446 (93.11%) 362 (76.05%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 0 (0.00%) 1234 (37.38%)
LVX Resistance 124 (24.55%) 117 (24.43%) 129 (27.10%) 96 (17.81%) 97 (19.25%) 116 (18.89%) 35 (19.02%) 714 (21.63%)
Intermediate 72 (14.26%) 50 (10.44%) 101 (21.22%) 271 (50.28%) 231 (45.83%) 434 (70.68%) 142 (77.17%) 1301 (39.41%)
Sensitivity 267 (52.87%) 306 (63.88%) 243 (51.05%) 169 (31.35%) 172 (34.13%) 61 (9.93%) 4 (2.17%) 1222 (37.02%)